Mark Taylor
Impact in
- Nephrology top 5%
- Renal Diseases and Glomerulopathies
-
- Amyloidosis: Diagnosis, Treatment, Outcomes
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 13
- Spectroscopy 10
- Mass Spectrometry Techniques and Applications 5
- Analytical Chemistry and Chromatography 4
- Co-authors
- Christian K. Nickl (2 shared papers)Wolfgang R. Dostmann (2 shared papers)Werner Tegge (2 shared papers)Joseph E. Brayden (2 shared papers)Ronald Frank (2 shared papers)Anne B. McCoy (4 shared papers)Felician Muntean (4 shared papers)W. C. Lineberger (4 shared papers)
- Journals
- The Journal of Chemical Physics (3 papers)Neurology (2 papers)Frontiers in Cardiovascular Medicine (2 papers)Amyloid (2 papers)The Journal of Physical Chemistry A (2 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Mark Taylor
37 papers receiving 971 citations
Mark Taylor's Hit Papers
Peers
Comparison fields: 5 of 106
- Nephrology 153
- Molecular Biology 455
- Genetics 58
- Spectroscopy 96
- Physical and Theoretical Chemistry 50
Countries citing papers authored by Mark Taylor
This map shows the geographic impact of Mark Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Taylor more than expected).
Fields of papers citing papers by Mark Taylor
This network shows the impact of papers produced by Mark Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Taylor. The network helps show where Mark Taylor may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Taylor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial Hit paper breakdown → | 2022 | 239 |
| 2 | 2000 | 142 | |
| 3 | 2009 | 126 | |
| 4 | 2011 | 50 | |
| 5 | 1998 | 42 | |
| 6 | 2007 | 41 | |
| 7 | 1998 | 41 | |
| 8 | 2004 | 39 | |
| 9 | 2004 | 39 | |
| 10 | 2002 | 37 | |
| 11 | 1999 | 24 | |
| 12 | 2005 | 19 | |
| 13 | 1999 | 18 | |
| 14 | 2009 | 16 | |
| 15 | 2018 | 15 | |
| 16 | 2004 | 11 | |
| 17 | 1998 | 9 | |
| 18 | 1997 | 8 | |
| 19 | 2022 | 8 | |
| 20 | 2024 | 7 |
About Mark Taylor
Mark Taylor is a scholar working on Molecular Biology, Spectroscopy, Organic Chemistry, Atomic and Molecular Physics, and Optics and Nephrology, having authored 43 papers that have together received 995 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (13 papers), Advanced Chemical Physics Studies (6 papers), Chemical Reaction Mechanisms (6 papers), Mass Spectrometry Techniques and Applications (5 papers), Spectroscopy and Quantum Chemical Studies (4 papers), Free Radicals and Antioxidants (4 papers), Analytical Chemistry and Chromatography (4 papers) and Parathyroid Disorders and Treatments (4 papers). The work is most often cited by research in Nephrology (153 citations), Molecular Biology (455 citations), Genetics (58 citations), Spectroscopy (96 citations) and Physical and Theoretical Chemistry (50 citations). Mark Taylor has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Christian K. Nickl, Wolfgang R. Dostmann, Werner Tegge, Joseph E. Brayden, Ronald Frank, Anne B. McCoy, Felician Muntean, W. C. Lineberger, Leo Radom and Soon-Chai Low. Their work appears in journals such as The Journal of Chemical Physics, Neurology, Frontiers in Cardiovascular Medicine, Amyloid and The Journal of Physical Chemistry A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.